Sven Bucher

GAM Investment Management (Switzerland) AG (GAM Switzerland) is an asset management firm headquartered in Zurich, Switzerland. The firm was founded in 1983 and is owned by GAM Holding AG (SWX: GAM, ADR: GMHLY). GAM Switzerland provides active investment solutions and products for institutions, financial intermediaries and private investors.

UBS AG (Investment Management) (UBS-IM) is the Swiss investment management division of UBS AG, itself a subsidiary of UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. Formerly known as UBS Global Asset Management Switzerland, the firm was founded in 1998 when Union Bank of Switzerland and Swiss Bank Corporation merged. Headquartered in Zurich and has additional office in Basel, UBS-IM manages a range of investment funds and offers investment management services for institutional, corporate and private clients.

Credit Suisse AG (Private Banking) (CSPB) is the Zurich-based private banking division of Credit Suisse AG, itself a subsidiary of Credit Suisse Group AG (VX: CSGN) in Switzerland. Established in 1856, CSPB provides comprehensive advice and a range of investment products and services to private, corporate and institutional clients. The firm is a leading provider of innovative alternative investment products. Their wealth management solutions include tax planning, pension planning, life insurance solutions, wealth and inheritance advice, trusts and foundations.

Part of Ernst & Young Global Ltd., Ernst & Young AG is a Swiss company that provides accounting services. The company is based in Zurich, Switzerland.

M.M. Warburg Bank (Schweiz) AG (MMWB Schweiz) is the wholly-owned Swiss private banking subsidiary of M.M. Warburg & Co. KGoA, itself a subsidiary of M.M. Warburg & Co. Gruppe (GmbH & Co.) KGaA in Germany. Based in Zurich, MMWB Schweiz traces their history to 1880 when stock exchange member bank Schoop, Reiff & Co. was founded. In 1995, the bank was acquired by M.M. Warburg & Co.and renamed M.M. Warburg Bank (Schweiz) AG. MMWB Schweiz provides investment advisory and discretionary investment management services to a range of clients including high-net worth individuals, institutions and financial intermediaries.

UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals.

PricewaterhouseCoopers AG provides assurance, tax and advisory services. The company is headquartered in Zurich, Switzerland.

Zürcher Kantonalbank (Investment Management) (ZKB-IM) is the investment management division of Zürcher Kantonalbank, a Swiss full-service bank headquartered in Zurich. Founded in 1870, ZKB-IM performs the bank's investment activities, including financial advisory services, research, trading, and asset management. The asset management division provides investment solutions for institutional, corporate and private clients, managing discretionary mandates and the ZKB range of mutual funds. Their mission includes fostering economic growth in the Canton of Zurich.

Credit Suisse Securities Europe Ltd. (Switzerland) is the Swiss broker/dealer division of Credit Suisse Securities Europe Ltd. in Great Britain. They are ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Headquartered in Zurich, the firm offers equities and fixed income sales and trading services, and provides access to a range of debt and equity securities, derivative products and financing opportunities across the capital spectrum for corporate, sovereign and institutional clients.

Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.

Kizoo Technology Capital GmbH (KIZOO) is the venture capital arm of Atevia AG, itself a subsidiary of Cinetic Gesellschaft zur Entwicklung & Vertrieb von Medien. The firm was founded by Michael Greve, Matthias Hornberger, and Frank Schüler in 2006. It is headquartered in Karlsruhe, Germany.

BFW Holding AG engages in the provision of financial services. It also holds participating interests in firms, particularly in the real estate and finance sectors. The company is headquartered in Frauenfeld, Switzerland.

Deutsche Bank (Suisse) SA (Broker) (Deutsche Bank Switzerland) is the securities brokerage division of Switzerland-based Deutsche Bank (Suisse) SA, which is owned by Deutsche Bank AG (ETR: DBK) in Germany. The firm is headquartered in Zurich and was founded in 1980. Deutsche Bank Switzerland is responsible for macro and microanalysis within Deutsche Bank Group and acts as consultant for the bank, its clients and stakeholders. They analyze relevant trends for the bank in financial markets, the economy and society and highlight risks and opportunities. The firm delivers high-quality, independent analysis and actively promotes public debate on economic, fiscal, labor market and social policy issues.

Luzerner Kantonalbank AG (Private Banking) (LUKB-PB) is the private banking division of State of Lucerne-owned Luzerner Kantonalbank AG in Switzerland. Founded in 1850 as KantonaleSpar-und Leihkasse, the firm changed their name to Luzerner Kantonalbank in 1892. In 2006, they acquired private banking team Adler & Co. PrivatbankAG and in 2010 Adler & Co. PrivatbankAG merged into Luzerner Kantonalbank AG. LUKB-PB is based in Lucerne with an additional office in Zurich. They providesa full range of private banking services, including wealth management advice, for small and medium-sized enterprises in Canton Lucerne and the rest of German-speaking Switzerland.

APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria.

GAM (Italia) SGR SpA (GAM Italia) is the asset management subsidiary of GAM (Switzerland) Holding AG, headquartered in Milan. They are ultimately owned by GAM Holding AG (SWX: GAM) in Switzerland. GAM Italia was founded in 2003 and offers active investment products and solutions for institutional investors, financial intermediaries, and private investors.

1741 Fund Solutions AG is an independent, management-owned fund management firm headquartered in St. Gallen, Swizterland. The firm was founded in 1998 and formerly known as Wegelin Fondsleitung AG and as Vescore Fondsleitung AG. 1741 Fund Solutions acts as Swiss representative for foreign investment funds distributed in Switzerland.

Aargauische Kantonalbank (Invt Mgmt) (AKB-IM) is the asset management division of state-owned Aargauische Kantonalbank, a cantonal bank headquartered in Aarau, Switzerland. Founded in 1913, AKB-IM provides investment advisory and management services to private and corporate clients.

Schweizerische Nationalbank (Investment Portfolio) (SNB-IP) is the investment portfolio division of Schweizerische Nationalbank (SW: SNBN) in Switzerland. The firm was founded in 1907 and is headquartered in Zurich. SNB-IP manages the assets of the Swiss National Bank, consisting of foreign currency, gold and Swiss francs, as determined by the established monetary order and the requirements of monetary policy.

BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland.

Swiss Fund Data AG is a joint venture between the Asset Management Association and Six Swiss Exchange. The private company is based in Zurich, Switzerland, and is monitored by the Federal Financial Aviation (FINMA). The Swiss company provides market data, investment statistics, and fund comparison services according to asset class, ETF, institutional fund, and sustainable fund. The company's website contains legal provisions, disclaimers, and data protection information. The company does not provide investment advice or recommendations for investment and other decisions. The company's website uses cookies that are stored on the user's computer. The company also provides web analysis with analysis tools of third parties such as Google Analytics.

JFG Life Sciences Stiftung der Universität Basel engages in the promotion of innovation transfer in the field of life sciences and related areas. It also supports knowledge and technology transfer at the University of Basel. The company was founded on December 20, 2018 and is headquartered Basel, Switzerland.

Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA.

LIfT BioSciences Ltd. is a pre-clinical stage biotech company based in Brighton, UK. LIfT BioSciences is developing a first-in-class alpha neutrophil cell therapy called N-Lift, which is produced from a patented process using exceptional stem cells, a proprietary enhancement media, and genetic engineering. The therapy is designed to destroy solid tumors both directly and indirectly by turning the tumor microenvironment against the tumor and recruiting the rest of the immune system to destroy it. The British company is working with a range of pharmaceutical license partners across oncology, immunology, neurology, and AMR to develop a portfolio of immune-modulatory alpha neutrophils for treating a range of therapeutic indications, including solid tumors. The company's goal is to deliver complete remission in high unmet need solid tumors before the decade is out. The company was founded in 2014 by Alexander William Blyth, who was inspired to create the company after his mother passed away from pancreatic cancer.

Indigita SA provides information technology services. The private company is located in Switzerland.

Sony Advanced Visual Sensing AG develops visual positioning systems applications for mobile devices. The company was founded by Christian Brändli and is headquartered in Zurich, Switzerland.

Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland.